DeutschNewstral
Article
bizjournals.com on 2015-06-17 15:39
Heart biotech BioCardia hopes to raise up to $58M in IPO
Related news
- Peninsula biotech fails to find buyers for its IPObizjournals.com
- Bay Area biotech boosts IPO targets by 38%, hopes to raise up to $254Mbizjournals.com
- BioCardia to raise up to $62 million in IPObizjournals.com
- Custom chip designer eASIC hopes to raise $75M in IPObizjournals.com
- Another Bay Area biotech files for an IPO, seeks to raise $100Mbizjournals.com
- Explosive Bay Area biotech sets range on IPO that could raise close to $500Mbizjournals.com
- Another Bay Area unicorn files for IPO, hopes to raise up to $100Mbizjournals.com
- Another Bay Area life science company targets IPO, hopes to raise $115Mbizjournals.com
- Another Bay Area life science company prices IPO, hopes to raise up to $122.4Mbizjournals.com
- Redwood City biotech boosts IPO targets, hopes to raise up to $184Mbizjournals.com
- Peninsula startup hopes to raise up to $98 million in what could be Bay Area's first IPO of 2018bizjournals.com
- Redwood City biopharma startup hopes to raise up to $98M in what could be Bay Area's first IPO of 2018bizjournals.com
- Xactly hopes to raise $75M in IPObizjournals.com
- Amid IPO rumors, biotech CEO crowdfunds for African woman's surgerybizjournals.com
- IPO-bound Bay Area biotech snags Big Pharma cancer dealbizjournals.com
- Biotech startup Global Blood Therapeutics files for $124.2M IPObizjournals.com
- Upsized and target-topping Bay Area biotech IPO scores $252Mbizjournals.com